Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia
about
The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.Pathophysiology of sleep apneaThe polymorphic and contradictory aspects of intermittent hypoxiaNFATc3 contributes to intermittent hypoxia-induced arterial remodeling in miceCarotid body potentiation during chronic intermittent hypoxia: implication for hypertensionMechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxiaEnhanced carotid body chemosensory activity and the cardiovascular alterations induced by intermittent hypoxiaEnhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processingEndothelin-1 induces contraction of female rat internal pudendal and clitoral arteries through ET(A) receptor and rho-kinase activation.Hypoxia. 3. Hypoxia and neurotransmitter synthesis.Role for PKCβ in enhanced endothelin-1-induced pulmonary vasoconstrictor reactivity following intermittent hypoxiaRegulation of blood pressure and salt homeostasis by endothelin.Cerebrovascular consequences of obstructive sleep apneaPhosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxiaCan O2 dysregulation induce premature aging?Chronic intermittent hypoxia increases sympathetic control of blood pressure: role of neuronal activity in the hypothalamic paraventricular nucleus.Vascular effects of intermittent hypoxiaIntermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.Endothelin-1 and ET receptors impair left ventricular function by mediated coronary arteries dysfunction in chronic intermittent hypoxia rats.Mechanisms of intermittent hypoxia induced hypertension.Endothelin-1-induced vasoconstriction does not require intracellular Ca²⁺ waves in arteries from rats exposed to intermittent hypoxia.Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.Role of Carotid Body in Intermittent Hypoxia-Related Hypertension.Cardiovascular and respiratory outcome of preconditioned rats submitted to chronic intermittent hypoxia.Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure.Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia.Intermittent hypoxia: endothelin-1 and hypoxic carotid body chemosensory potentiation.Chronic hypoxia alters fetal cerebrovascular responses to endothelin-1.Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study.Cardiovascular consequences of sleep apnea.Intermittent hypoxia: keeping it real.Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea.
P2860
Q30428971-AD636955-58B5-40C5-BA81-642F5399DF8FQ30440658-1FA79A3A-CCE5-44D7-A7BE-E8D42736B6E8Q33913792-DFEBD7CE-B889-423E-A791-F95DEB906E7BQ34092840-B6F4523D-7BC5-4755-8861-9030DB56C731Q34495929-7E2A0668-5492-4870-9C3C-FB62CA53E843Q34591791-F0C8A5A9-6A9F-407E-84DB-A9391DA96443Q34608364-8C74E96B-9BAF-4914-B885-E7DD6EA8FD28Q34624915-C4FE1E29-6EBE-4AC3-87EC-E56C7E82C217Q34700728-F9CD352B-3BFA-4EB0-B111-27B4FA98B458Q34782170-F9265D57-DB21-4335-B8DF-ED2B972B2558Q35543602-16A21352-C259-48C0-9E4D-ADAD88FA0A7FQ35609851-3705C18D-8CDB-41DC-9B36-A2B68A679B12Q36366284-49BE2771-2AE7-4A50-9C1B-2FD74958A346Q36497577-BEB34E72-43CA-4170-8FF7-719A2BEABD71Q37346880-CC12CB9C-72DC-4DD3-BB6F-5CCACD0DF81CQ37440591-21F13C0F-3FF1-4D4F-9D65-E06D95441E7AQ37511424-D5637BCB-2DD7-4B3C-8BCD-9A15A5E0A801Q37519229-F2B3BFD2-AA1F-4E98-AC83-F901C4498B57Q37599590-E8AEE8BA-18C4-4479-AF13-1EBCFB701B66Q37612046-053CE42C-59F1-4F7F-BB9B-94B459CB2146Q37629265-BBAD1B27-3D51-4CB8-A6D0-FF560A41FBF0Q38919168-EC1FAB84-9E0E-45EF-A332-42A802CFDD9BQ39268819-780659E3-C6AD-4E09-A0F8-F642B1B71A71Q40714653-242627C3-8CBD-476E-8262-AA23BF5281D2Q44011217-F78C2564-271D-44A4-9332-13E4F6018DA9Q44029636-B7858660-0F58-4503-8E93-511C6D4D6026Q44843500-2A9C738C-26CD-44CF-8D82-626D497FCAB7Q46056406-42A12122-0985-4731-87FD-6183BAC55DBAQ47911630-A42C62E9-EB5D-4282-8911-3323F9B1E4BCQ48275734-42FA2432-EADC-4849-8A7F-F71CE723D7D9Q48405221-966BC1F6-05D1-420F-B3FD-E4DD94ABDEA1Q55346247-07C69F73-0858-4307-9F28-A91FEA18F5B1
P2860
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@ast
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@en
type
label
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@ast
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@en
prefLabel
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@ast
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@en
P2093
P2860
P1476
Endothelin type A receptor ant ...... eucapnic intermittent hypoxia
@en
P2093
Ana Q Silva
Benjimen R Walker
Hemanth Pai
Kyan J Allahdadi
Leif D Nelin
Nancy L Kanagy
Tom W Cherng
P2860
P304
P356
10.1152/AJPHEART.91477.2007
P577
2008-05-30T00:00:00Z